Merck, a globally leading technology company, announced on July 12th that it has successfully commercialized its first GMP grade cell culture medium (CCM) production line in China. Merck has invested approximately 6.6 million euros in its manufacturing base located in Nantong, an industrial hub in the Yangtze River Delta region, in an effort to meet the growing demand in the Chinese market for high-quality customized cell culture media (used in fields such as biopharmaceuticals, vaccines, and new therapies).

This localized commercial production can enable Chinese customers to reliably and efficiently obtain Merck's highly reputable customized cell culture medium products and services. With its rich and professional formula experience and knowledge, Merck can produce high-quality customized cell culture media and innovative solutions based on specific formulas, ensuring batch uniformity and production efficiency of products.

Merck Life Sciences China Managing Director Wu Bo said, "This investment further expands Merck's business territory and capabilities in China, fulfilling our commitment to promoting the development of the local biopharmaceutical industry. The implementation of this cell culture medium production line fully reflects our efforts and vision to actively enhance patient care through Merck's innovative spirit and global expert network.

The newly completed GMP level production line at Merck Nantong Life Science Center (GMP stands for Good Manufacturing Practice, which is a regulation guiding the production and quality management of food, drugs, and medical products) uses all qualified and reliable culture medium raw materials, enabling customers to achieve a smooth transition from pilot scale to commercial scale cell culture production, and providing comprehensive regulatory documents. In addition to customizing dry powder cell culture media for customers, Merck will also provide customized services and operational support to help local biopharmaceutical companies optimize their process flow and shorten product launch time. The production line will significantly improve the delivery efficiency of Merck's cell culture medium products in China.

Merck provides comprehensive innovative solutions for local and global biopharmaceutical customers. In addition to cell culture media, Merck Life Sciences also offers a wide range of products including cell lines, bioreactors, filters, fillers, chromatography, pharmaceutical raw materials, and more. From process development to process scale-up production, Merck's process solutions provide comprehensive end-to-end services for biopharmaceutical companies, actively benefiting patients and contributing to the development of global health.

Source: https://pharm.jgvogel.cn/c1447308.shtml